Discover
Study to help HIV-infected women live normal lives
Some antiretroviral therapies used in sub-Saharan Africa are found to not work well with contraceptives.
Aug 20, 2015

The scientist and his chicken soup
Every time cold season rolls around, so do home remedies, including Stephen Rennard, M.D., and his famous study of chicken soup.
Feb 13, 2015

Get inside the killer virus and learn how it succeeds in disrupting the immune system.
Feb 13, 2015

Sticky cells are a sticky issue
Tight junctions and migrations of epithelial cells are under study in the College of Dentistry.
Feb 13, 2015

COBREs build centers of excellence
Research centers of excellence develop with the help of grants from the National Institutes of Health.
Feb 13, 2015
Storm chaser to headline 2015 Nebraska Science Festival
Reed Timmer will kick off the biggest science festival in Nebraska in April.
Feb 13, 2015

Time travel with a disease detective
His first time in Africa, Dr. Khan’s job was to identify patient zero and attempt to determine the natural reservoir – from which the disease had come. He had one major drawback – he couldn’t speak French and would need an interpreter. Fortunately, two other teammates knew the language.
Feb 13, 2015

Dr. Smith’s COBRE grant renewed for phase 3; projects being considered
Shelley Smith, Ph.D., director of developmental neuroscience at UNMC’s Munroe-Meyer Institute and professor of pediatrics, recently learned her COBRE grant, “The Molecular Basis of Neurosensory Systems” was renewed for five years by the National Institutes of Health.
Feb 13, 2015

COBRE renewal expands nanothechnology research
UNMC researcher Tatiana Bronich, Ph.D., is the principal investigator on the grant. Dr. Bronich is the Parke-Davis Professor in Pharmaceutics, UNMC College of Pharmacy, and co-director of the Center for Drug Delivery and Nanomedicine.
Feb 13, 2015

Cellular signaling is focus of COBRE
To Keith Johnson, Ph.D., director of the Nebraska Center for Cellular Signaling (NCCS) in the College of Dentistry, reaching phase III status, with a $4.9 million grant renewal, means the opportunity to turn a corner.
Feb 13, 2015
